Physiomics Share Price (PYC)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Physiomics Plc	LSE:PYC	London	Ordinary Share	GB00BDR6W943	ORD 0.4P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.00	0.0%	2.45	50	08:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
2.30		2.60	2.45	2.45	2.45

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Health Care Equipment & Services	0.43	-0.26	-0.31		2

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
12:05:03	O	50	2.42	GBX

Related Shares
Smith & Nephew (SN.), Nmc Health (NMC), Novacyt (NCYT), Salvarx (SALV)

Physiomics (PYC) Latest News

Physiomics News

Date	Time	Source	Headline
30/9/2019	16:06	ALNC	Physiomics Achieves Record Annual Total Income And Narrows Loss
30/9/2019	07:56	ALNCF	Alliance News Flash Headline
30/9/2019	07:00	UKREG	Physiomics PLC Final Results for the Year Ended 30 June 2019
05/8/2019	07:00	UKREG	Physiomics PLC Director Dealing
30/7/2019	12:21	ALNC	Physiomics Says Annual Performance In Line With Analyst Forecasts
30/7/2019	07:00	UKREG	Physiomics PLC Trading Update
22/7/2019	09:03	UKREG	Physiomics PLC Holding(s) in Company
08/7/2019	11:19	ALNC	Physiomics Signs Agreement With Bicycle Therapeutics, Cancer Research
08/7/2019	07:00	RNSNON	Physiomics PLC Agreement with Bicycle and Cancer Research UK
02/7/2019	13:30	UKREG	Physiomics PLC Holding(s) in Company

More Physiomics News

Physiomics Takeover Rumours

Physiomics (PYC) Share Charts

1 Year Physiomics Chart

1 Month Physiomics Chart

Intraday Physiomics Chart

Physiomics (PYC) Discussions and Chat

Physiomics Forums and Chat

Date	Time	Title	Posts
14/10/2019	15:52	Physiomics - Cancer Treatment tech firm working with Merck + Oxford Uni	4,588
30/9/2019	08:08	PYC - Podcast	-
07/8/2019	15:36	Physiomics with Charts & News	13,716
31/1/2018	08:34	PHYSIOMICS plc Virtual Tumor platform	4,933
01/12/2017	19:18	RGP NEXT MULTI BAGGER TODAY 50p	4

Add a New Thread

Physiomics (PYC) Most Recent Trades

No Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type

View all Physiomics trades in real-time

Physiomics (PYC) Top Chat Posts

Date	Subject
20/10/2019 09:20	Physiomics Daily Update: Physiomics Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker PYC. The last closing price for Physiomics was 2.45p. Physiomics Plc has a 4 week average price of 2.45p and a 12 week average price of 2.45p. The 1 year high share price is 5.53p while the 1 year low share price is currently 2.45p. There are currently 71,910,394 shares in issue and the average daily traded volume is 444,671 shares. The market capitalisation of Physiomics Plc is £1,761,804.65. Read Full Thread Reply
16/7/2019 12:34	herb clark: Will they need to raise cash? If they have landed either of these clients what do you think the share price will rise to? Read Full Thread Follow Reply
08/7/2019 21:31	davevt: They know if they keep listing the revenue it will only send the share price down. Read Full Thread Follow Reply
02/7/2019 22:37	davevt: Every single news release they have said the value, and every time it has pushed the share price DOWN. He's learned now he doesn't have to list the value, so he won't. It will have been another 35k contract, that's even if any work was actually actioned. The rns was more of 'we will be doing some work for them'. And you do realise this holding rns is only about £60k worth? I have more than that invested in one of my mining shares. Read Full Thread Follow Reply
24/5/2019 16:16	davevt: Myamay, you just proved the point. All of his other shares options are at lower price points, and silly high ones. you sell off the highest ones first, otherwise if the share price is below the option price, you can't sell them at all. Read Full Thread Follow Reply
01/5/2019 14:16	herb clark: Are they not obliged to let shareholders know who the undisclosed companies are? This may have a material effect on the share price? Read Full Thread Follow Reply
13/12/2018 10:50	badger60: Institutional OwnershipInstitutions account for 77.04% of PYC's outstanding shares, a significant enough holding to move stock prices if they start buying and selling in large quantities, especially when there are relatively small amounts of shares available on the market to trade. Although PYC has a high institutional ownership, such stock moves, in the short-term, are more commonly linked to a particular type of active institutional investors hedge funds. In the case of PYC, investors need not worry about such volatility considering active hedge funds don't have a significant stake. However, we should dig deeper into PYC's ownership structure and find out how other key ownership classes can affect its investment profile.Insider OwnershipInsiders form a group of important ownership types as they manage the company's operations and decide the best use of capital. Insider ownership has been linked to better alignment between management and shareholders. Although individuals in PYC hold only a 1.98% stake, it's a good sign for shareholders as the company's executives and directors have their incentives directly linked to the company's performance. In addition to this, it may be interesting to look at insider buying and selling activities. Keep in mind that buying may be sign of upbeat future expectations, but selling doesn't necessarily mean the opposite as the insiders might just be doing it out of their personal financial needs.General Public OwnershipThe general public holds a substantial 20.92% stake in PYC, making it a highly popular stock among retail investors. This level of ownership gives retail investors the power to sway key policy decisions such as board composition, executive compensation, and potential acquisitions. This is a positive sign for an investor who wants to be involved in key decision-making of the company.Private Company OwnershipAnother group of owners that a potential investor in PYC should consider are private companies, with a stake of 0.028%. While they invest more often due to strategic interests, an investment can also be driven by capital gains through share price appreciation. However, an ownership of this size may be relatively insignificant, meaning that these shareholders may not have the potential to influence PYC's business strategy. Thus, investors not need worry too much about the consequences of these holdings. Read Full Thread Follow Reply
10/6/2018 15:31	pwhite73: OBD The current share price does not represent or misrepresent any value. The current share price is where mug punters are buying in order to support the next placing. The value of an AIM company and its share price completely divorced about 5 years ago. When was the last time you heard the term Price Earnings Ratio applied to an AIM stock. It cannot be that PYC was worth 32p per share in December 2017 valuing the company at £19 million and today the placing has valued the same company at just £2.8 million. Where has £16 million of value disappeared to in the space of seven months. You may not know where the share price will be in one years time but I certainly do. It will be back to 1p and this time it will stay there because mug punters are not going to be fooled again (he thinks!!). I have stated before and I'll say so again if it had not been for the November 2017 frenzy I believe PYC would have sought to exit from the AIM. Read Full Thread Follow Reply
27/12/2017 11:08	margic: It's a good thing for the PYC share price that eyes have just come off this. As buyers start to return this can move very very quick before the herd arrive and when the herd arrive we spike. Signal to take profit and re-load as the herd exit with their losses and smaller profits. Hope to see this 10p+ before volumes really pick up. Keep watch as PYC can flash bang wallop! Read Full Thread Follow Reply
18/12/2017 09:06	the stigologist: Todays VAL Valirx news on VAL201 is also great news for PYC. Expect PYC share price to follow VAL up Read Full Thread Follow Reply
17/12/2017 11:28	margic: Great stuff mate and exactly what I was hoping for, you've opened the doors for everyone to take note and find where to search, it's research and posts like that, that can move a stock and why not, there new information to see for investors to start predicting a value and assessing the share price tools to decide if PYC represents value. Centara is a great example, I highly doubt PYC would be taken out for anywhere near that figure based on the past but then again, was it here I read the directors have been ousted? That might change the picture. The bod I remember for years ago were no good to share holders but then again, why would you want long term shareholders when you have a big big play behind closed doors and a shocking share price. Price makes the mouth water now. 11.5p circa £6mil market cap, in a market that can quickly add £50mil valve on anything material that investors can put there eyes on. Even the $32mil take over in 2012 coming out of the burst. More money is spent now and it doesn't take much for a big boy to offer £35-50mil for a small slice, it helps them balance their spending. As I understand it, big pharmacy have a budget quota that must be spent year on year on certain aspects of the business and accumulating businesses, investment partnerships, support and R&D have the highest budgets set in both fiscal cash and time. These budgets. I may be wrong but GSK used to spend like 1bil dollars min a year on failed products before the 80's even. Certainly with now only 57odd mil shares in circulation this is a good time for PYC. I'm sure they can prove the markets cap to £12-15mil and then raising money to boost the line will become comfortable. Unless a take over offer happens out of no where you'd have to expect PYC to place just over 100mil shares, but it's very possible they could secure £10-30mil doing that. Big money for them, not sure they've ever had that at their disposal. As always it will be down to the bod and how soon they want to make their money. Many old money directors have 50-75years for their plays to come good.Is there any key news expected from the faithful? How do you see the BOD moving the company going forward, has anyone meet them or heard them speak? Thanks for the informative stuff stig. I'm only just flirting back in the aim market, I'm a technical trader now with currency's but I do like the aim. It seems now is like 2007-2011 all over again. Rises do seem much bigger. A good start for me has been some of the oldies im familiar with have been squeezed almost to the max and everything is jumping like true penny stocks should.PYC for starters, great news, big share price jump, hype, 57 something mil shares £6mil value, same as always, jumped in with 3mil market cap, can always go £12-15mil outta now where £35-50mil on transformational news, and £100mil + on a well sourced city take over rumour or bid. Bid less likely in normal terms but then again, Takeovers in the Pharma game are normally as good if not better than the tech industry. Disney splashing out £34bil, for essentially parts of a business, imagine what big pharmacy made will pay to wrap a deal up quick. It's not a ramp but I do know if GSK want a business they think a rival will want, they make an offer that won't be matched to conduct a move super quick. If PYC was valued by a proper surveying team at say £65mil (figure I've come up with based off others) , and no one was interested then it's a 20mil offer for part. If other firms are interested it's £80mil+, if a major rival is sniffing, £150-180mil+ plus part retention, if they feel a rival will bid, they'll re-visit alternatives, if they believe PYC to be better than all the rest, then you could be actually looking £500mil + you get a bidding war on that, who knows from there. That's how I see it. Read Full Thread Follow Reply

Physiomics share price data is direct from the London Stock Exchange

Your Recent History

LSE

PYC

Physiomics

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20191020 08:58:55